1
|
Rossi GR, Sun J, Lin CY, Wong JK, Alim L, Lam PY, Khosrotehrani K, Wolvetang E, Cheetham SW, Derrick EB, Amoako A, Lehner C, Brooks AJ, Beavis PA, Souza-Fonseca-Guimaraes F. A scalable, spin-free approach to generate enhanced induced pluripotent stem cell-derived natural killer cells for cancer immunotherapy. Immunol Cell Biol 2024. [PMID: 39269338 DOI: 10.1111/imcb.12820] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2024] [Revised: 08/26/2024] [Accepted: 08/26/2024] [Indexed: 09/15/2024]
Abstract
Natural killer (NK) cells play a vital role in innate immunity and show great promise in cancer immunotherapy. Traditional sources of NK cells, such as the peripheral blood, are limited by availability and donor variability. In addition, in vitro expansion can lead to functional exhaustion and gene editing challenges. This study aimed to harness induced pluripotent stem cell (iPSC) technology to provide a consistent and scalable source of NK cells, overcoming the limitations of traditional sources and enhancing the potential for cancer immunotherapy applications. We developed human placental-derived iPSC lines using reprogramming techniques. Subsequently, an optimized two-step differentiation protocol was introduced to generate high-purity NK cells. Initially, iPSCs were differentiated into hematopoietic-like stem cells using spin-free embryoid bodies (EBs). Subsequently, the EBs were transferred to ultra-low attachment plates to induce NK cell differentiation. iPSC-derived NK (iNK) cells expressed common NK cell markers (NKp46, NKp30, NKp44, CD16 and eomesodermin) at both RNA and protein levels. iNK cells demonstrated significant resilience to cryopreservation and exhibited enhanced cytotoxicity. The incorporation of a chimeric antigen receptor (CAR) construct further augmented their cytotoxic potential. This study exemplifies the feasibility of generating iNK cells with high purity and enhanced functional capabilities, their improved resilience to cryopreservation and the potential to have augmented cytotoxicity through CAR expression. Our findings offer a promising pathway for the development of potential cellular immunotherapies, highlighting the critical role of iPSC technology in overcoming challenges associated with traditional NK cell sources.
Collapse
Affiliation(s)
- Gustavo R Rossi
- Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia
| | - Jane Sun
- Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia
| | - Cheng-Yu Lin
- Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia
| | - Joshua Km Wong
- Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia
| | - Louisa Alim
- Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia
| | - Pui Yeng Lam
- Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia
| | - Kiarash Khosrotehrani
- Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia
| | - Ernst Wolvetang
- Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, QLD, Australia
| | - Seth W Cheetham
- Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, QLD, Australia
- BASE Facility, University of Queensland, St Lucia, QLD, Australia
| | - Emily B Derrick
- Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia
| | - Akwasi Amoako
- The Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
| | - Christoph Lehner
- The Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
| | - Andrew J Brooks
- Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia
| | - Paul A Beavis
- Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia
| | | |
Collapse
|
2
|
Coënon L, Geindreau M, Ghiringhelli F, Villalba M, Bruchard M. Natural Killer cells at the frontline in the fight against cancer. Cell Death Dis 2024; 15:614. [PMID: 39179536 PMCID: PMC11343846 DOI: 10.1038/s41419-024-06976-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2024] [Revised: 07/31/2024] [Accepted: 08/05/2024] [Indexed: 08/26/2024]
Abstract
Natural Killer (NK) cells are innate immune cells that play a pivotal role as first line defenders in the anti-tumor response. To prevent tumor development, NK cells are searching for abnormal cells within the body and appear to be key players in immunosurveillance. Upon recognition of abnormal cells, NK cells will become activated to destroy them. In order to fulfill their anti-tumoral function, they rely on the secretion of lytic granules, expression of death receptors and production of cytokines. Additionally, NK cells interact with other cells in the tumor microenvironment. In this review, we will first focus on NK cells' activation and cytotoxicity mechanisms as well as NK cells behavior during serial killing. Lastly, we will review NK cells' crosstalk with the other immune cells present in the tumor microenvironment.
Collapse
Affiliation(s)
- Loïs Coënon
- IRMB, Univ Montpellier, INSERM, CHU Montpellier, Montpellier, France
| | - Mannon Geindreau
- Equipe TIRECs, Labellisée Ligue Contre le Cancer, Centre de Recherche INSERM CTM-UMR1231, Dijon, France
- University of Bourgogne Franche-Comté, Dijon, France
| | - François Ghiringhelli
- Equipe TIRECs, Labellisée Ligue Contre le Cancer, Centre de Recherche INSERM CTM-UMR1231, Dijon, France
- University of Bourgogne Franche-Comté, Dijon, France
- Platform of Transfer in Biological Oncology, Georges-François Leclerc Cancer Center, Dijon, France
| | - Martin Villalba
- IRMB, Univ Montpellier, INSERM, CHU Montpellier, Montpellier, France
- Institut du Cancer Avignon-Provence Sainte Catherine, Avignon, France
- IRMB, Univ Montpellier, INSERM, CHU Montpellier, CNRS, Montpellier, France
| | - Mélanie Bruchard
- Equipe TIRECs, Labellisée Ligue Contre le Cancer, Centre de Recherche INSERM CTM-UMR1231, Dijon, France.
- University of Bourgogne Franche-Comté, Dijon, France.
- Platform of Transfer in Biological Oncology, Georges-François Leclerc Cancer Center, Dijon, France.
| |
Collapse
|
3
|
Vaz da Luz KT, Gonçalves JP, de Lima Bellan D, Visnheski BRC, Schneider VS, Cortes Cordeiro LM, Vargas JE, Puga R, da Silva Trindade E, de Oliveira CC, Simas FF. Molecular weight-dependent antitumor effects of prunes-derived type I arabinogalactan on human and murine triple wild-type melanomas. Carbohydr Res 2024; 535:108986. [PMID: 38042036 DOI: 10.1016/j.carres.2023.108986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2023] [Revised: 10/28/2023] [Accepted: 11/17/2023] [Indexed: 12/04/2023]
Abstract
The regulation of metastasis-related cellular aspects of two structurally similar AGIs from prunes tea infusion, with different molar masses, was studied in vitro against Triple Wild-Type metastatic melanoma (TWM) from murine and human origin. The higher molar mass AGI (AGI-78KDa) induced TWMs cells death and, in murine cell line, it decreased some metastasis-related cellular processes: invasiveness capacity, cell-extracellular matrix interaction, and colonies sizes. The lower molar mass AGI (AGI-12KDa) did not induce cell death but decreased TWMs proliferation rate and, in murine cell line, it decreased cell adhesion and colonies sizes. Both AGIs alter the clonogenic capacity of human cell line. In spite to understand why we saw so many differences between AGIs effects on murine and human cell lines we performed in silico analysis that demonstrated differential gene expression profiles between them. Complementary network topological predictions suggested that AGIs can modulate multiple pathways in a specie-dependent manner, which explain differential results obtained in vitro between cell lines. Our results pointed to therapeutic potential of AGIs from prunes tea against TWMs and showed that molecular weight of AGIs may influence their antitumor effects.
Collapse
Affiliation(s)
- Keila Taiana Vaz da Luz
- Laboratory of Inflammatory and Neoplastic Cells, Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal Do Paraná (UFPR), Av Cel Francisco H Dos Santos, s/n, CEP 81530-980, Curitiba, PR, Brazil
| | - Jenifer Pendiuk Gonçalves
- Laboratory of Inflammatory and Neoplastic Cells, Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal Do Paraná (UFPR), Av Cel Francisco H Dos Santos, s/n, CEP 81530-980, Curitiba, PR, Brazil
| | - Daniel de Lima Bellan
- Laboratory of Inflammatory and Neoplastic Cells, Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal Do Paraná (UFPR), Av Cel Francisco H Dos Santos, s/n, CEP 81530-980, Curitiba, PR, Brazil
| | - Bruna Renata Caitano Visnheski
- Laboratory of Inflammatory and Neoplastic Cells, Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal Do Paraná (UFPR), Av Cel Francisco H Dos Santos, s/n, CEP 81530-980, Curitiba, PR, Brazil
| | - Vanessa Suzane Schneider
- Biochemistry and Molecular Biology Department, Section of Biological Sciences, UFPR, Av Cel Francisco H Dos Santos, s/n, CEP 81530-980, Curitiba, PR, Brazil
| | - Lucimara Mach Cortes Cordeiro
- Biochemistry and Molecular Biology Department, Section of Biological Sciences, UFPR, Av Cel Francisco H Dos Santos, s/n, CEP 81530-980, Curitiba, PR, Brazil
| | - José Eduardo Vargas
- Laboratory of Inflammatory and Neoplastic Cells, Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal Do Paraná (UFPR), Av Cel Francisco H Dos Santos, s/n, CEP 81530-980, Curitiba, PR, Brazil
| | - Renato Puga
- Hermes Pardini Institute, CEP 04038-030, São Paulo, SP, Brazil
| | - Edvaldo da Silva Trindade
- Laboratory of Inflammatory and Neoplastic Cells, Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal Do Paraná (UFPR), Av Cel Francisco H Dos Santos, s/n, CEP 81530-980, Curitiba, PR, Brazil
| | - Carolina Camargo de Oliveira
- Laboratory of Inflammatory and Neoplastic Cells, Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal Do Paraná (UFPR), Av Cel Francisco H Dos Santos, s/n, CEP 81530-980, Curitiba, PR, Brazil
| | - Fernanda Fogagnoli Simas
- Laboratory of Inflammatory and Neoplastic Cells, Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal Do Paraná (UFPR), Av Cel Francisco H Dos Santos, s/n, CEP 81530-980, Curitiba, PR, Brazil.
| |
Collapse
|
4
|
Hogwood J, Mulloy B, Lever R, Gray E, Page CP. Pharmacology of Heparin and Related Drugs: An Update. Pharmacol Rev 2023; 75:328-379. [PMID: 36792365 DOI: 10.1124/pharmrev.122.000684] [Citation(s) in RCA: 20] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Revised: 11/04/2022] [Accepted: 11/08/2022] [Indexed: 02/17/2023] Open
Abstract
Heparin has been used extensively as an antithrombotic and anticoagulant for close to 100 years. This anticoagulant activity is attributed mainly to the pentasaccharide sequence, which potentiates the inhibitory action of antithrombin, a major inhibitor of the coagulation cascade. More recently it has been elucidated that heparin exhibits anti-inflammatory effect via interference of the formation of neutrophil extracellular traps and this may also contribute to heparin's antithrombotic activity. This illustrates that heparin interacts with a broad range of biomolecules, exerting both anticoagulant and nonanticoagulant actions. Since our previous review, there has been an increased interest in these nonanticoagulant effects of heparin, with the beneficial role in patients infected with SARS2-coronavirus a highly topical example. This article provides an update on our previous review with more recent developments and observations made for these novel uses of heparin and an overview of the development status of heparin-based drugs. SIGNIFICANCE STATEMENT: This state-of-the-art review covers recent developments in the use of heparin and heparin-like materials as anticoagulant, now including immunothrombosis observations, and as nonanticoagulant including a role in the treatment of SARS-coronavirus and inflammatory conditions.
Collapse
Affiliation(s)
- John Hogwood
- Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom (B.M., E.G., C.P.P.); National Institute for Biological Standards and Control, South Mimms, Hertfordshire, United Kingdom (J.H., E.G.) and School of Pharmacy, University College London, London, United Kingdom (R.L.)
| | - Barbara Mulloy
- Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom (B.M., E.G., C.P.P.); National Institute for Biological Standards and Control, South Mimms, Hertfordshire, United Kingdom (J.H., E.G.) and School of Pharmacy, University College London, London, United Kingdom (R.L.)
| | - Rebeca Lever
- Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom (B.M., E.G., C.P.P.); National Institute for Biological Standards and Control, South Mimms, Hertfordshire, United Kingdom (J.H., E.G.) and School of Pharmacy, University College London, London, United Kingdom (R.L.)
| | - Elaine Gray
- Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom (B.M., E.G., C.P.P.); National Institute for Biological Standards and Control, South Mimms, Hertfordshire, United Kingdom (J.H., E.G.) and School of Pharmacy, University College London, London, United Kingdom (R.L.)
| | - Clive P Page
- Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom (B.M., E.G., C.P.P.); National Institute for Biological Standards and Control, South Mimms, Hertfordshire, United Kingdom (J.H., E.G.) and School of Pharmacy, University College London, London, United Kingdom (R.L.)
| |
Collapse
|
5
|
Todosenko N, Yurova K, Khaziakhmatova O, Malashchenko V, Khlusov I, Litvinova L. Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells. Pharmaceutics 2022; 14:pharmaceutics14102181. [PMID: 36297616 PMCID: PMC9612132 DOI: 10.3390/pharmaceutics14102181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2022] [Revised: 09/29/2022] [Accepted: 10/10/2022] [Indexed: 11/23/2022] Open
Abstract
One of the main problems of modern health care is the growing number of oncological diseases both in the elderly and young population. Inadequately effective chemotherapy, which remains the main method of cancer control, is largely associated with the emergence of multidrug resistance in tumor cells. The search for new solutions to overcome the resistance of malignant cells to pharmacological agents is being actively pursued. Another serious problem is immunosuppression caused both by the tumor cells themselves and by antitumor drugs. Of great interest in this context is heparin, a biomolecule belonging to the class of glycosaminoglycans and possessing a broad spectrum of biological activity, including immunomodulatory and antitumor properties. In the context of the rapid development of the new field of “osteoimmunology,” which focuses on the collaboration of bone and immune cells, heparin and delivery systems based on it may be of intriguing importance for the oncotherapy of malignant bone tumors. Osteosarcoma is a rare but highly aggressive, chemoresistant malignant tumor that affects young adults and is characterized by constant recurrence and metastasis. This review describes the direct and immune-mediated regulatory effects of heparin and drug delivery systems based on it on the molecular mechanisms of (multiple) drug resistance in (onco) pathological conditions of bone tissue, especially osteosarcoma.
Collapse
Affiliation(s)
- Natalia Todosenko
- Center for Immunology and Cellular Biotechnology, Immanuel Kant Baltic Federal University, 236001 Kaliningrad, Russia
| | - Kristina Yurova
- Center for Immunology and Cellular Biotechnology, Immanuel Kant Baltic Federal University, 236001 Kaliningrad, Russia
| | - Olga Khaziakhmatova
- Center for Immunology and Cellular Biotechnology, Immanuel Kant Baltic Federal University, 236001 Kaliningrad, Russia
| | - Vladimir Malashchenko
- Center for Immunology and Cellular Biotechnology, Immanuel Kant Baltic Federal University, 236001 Kaliningrad, Russia
| | - Igor Khlusov
- Department of Morphology and General Pathology, Siberian State Medical University, 634050 Tomsk, Russia
| | - Larisa Litvinova
- Center for Immunology and Cellular Biotechnology, Immanuel Kant Baltic Federal University, 236001 Kaliningrad, Russia
- Correspondence:
| |
Collapse
|
6
|
A Brief Analysis of Tissue-Resident NK Cells in Pregnancy and Endometrial Diseases: The Importance of Pharmacologic Modulation. IMMUNO 2021. [DOI: 10.3390/immuno1030011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
NK cells are lymphocytes involved in the innate and adaptative immune response. These cells are located in peripheral blood and tissues with ample functions, from immune vigilant to tolerogenic reactions. In the endometrium, NK cell populations vary depending on age, hormones, and inflammation. When pregnancy occurs, tissue-resident NK cells and conventional NK cells are recruited to protect the fetus, a tolerogenic response. On the contrary, in the inflamed endometrium, various inflammatory cells down-regulate NK tolerance and impair embryo implantation. Therefore, NK cells’ pharmacological modulation is difficult to achieve. Several strategies have been used, from progesterone, lipid emulsions to steroids; the success has not been as expected. However, new therapeutic approaches have been proposed to decrease the endometrial inflammatory burden and increase pregnancy success based on understanding NK cell physiology.
Collapse
|
7
|
Gonçalves JP, da Cruz AF, Nunes ÁM, Meneghetti MR, de Barros HR, Borges BS, de Medeiros LCAS, Soares MJ, Dos Santos MP, Grassi MT, Rossi GR, Bellan DL, Biscaia SMP, Cristal AM, Buzzo JLA, Ribeiro YC, Acco A, Cardoso MB, Simas FF, Trindade ES, Riegel-Vidotti IC, de Oliveira CC. Biocompatible gum arabic-gold nanorod composite as an effective therapy for mistreated melanomas. Int J Biol Macromol 2021; 185:551-561. [PMID: 34216657 DOI: 10.1016/j.ijbiomac.2021.06.172] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 05/23/2021] [Accepted: 06/26/2021] [Indexed: 01/13/2023]
Abstract
Advanced melanoma patients that are not included in common genetic classificatory groups lack effective and safe therapeutic options. Chemotherapy and immunotherapy show unsatisfactory results and devastating adverse effects for these called triple wild-type patients. New approaches exploring the intrinsic antitumor properties of gold nanoparticles might reverse this scenario as a safer and more effective alternative. Therefore, we investigated the efficacy and safety of a composite made of gum arabic-functionalized gold nanorods (GA-AuNRs) against triple wild-type melanoma. The natural polymer gum arabic successfully stabilized the nanorods in the biological environment and was essential to improve their biocompatibility. In vivo results obtained from treating triple wild-type melanoma-bearing mice showed that GA-AuNRs remarkably reduced primary tumor growth by 45%. Furthermore, GA-AuNRs induced tumor histological features associated with better prognosis while also reducing superficial lung metastasis depth and the incidence of intrapulmonary metastasis. GA-AuNRs' efficacy comes from their capacity to reduce melanoma cells ability to invade the extracellular matrix and grow into colonies, in addition to a likely immunomodulatory effect induced by gum arabic. Additionally, a broad safety investigation found no evidence of adverse effects after GA-AuNRs treatment. Therefore, this study unprecedentedly reports GA-AuNRs as a potential nanomedicine for advanced triple wild-type melanomas.
Collapse
Affiliation(s)
- Jenifer P Gonçalves
- Laboratory of Inflammatory and Neoplastic Cells/Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal do Paraná (UFPR), Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Anderson F da Cruz
- Laboratory of Inflammatory and Neoplastic Cells/Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal do Paraná (UFPR), Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Ábner M Nunes
- Catalysis and Chemical Reactivity Group, Institute of Chemistry and Biotechnology, Universidade Federal de Alagoas, Av. Lourival de Melo Mota, s/n, CEP 57072-900 Maceió, AL, Brazil
| | - Mario R Meneghetti
- Catalysis and Chemical Reactivity Group, Institute of Chemistry and Biotechnology, Universidade Federal de Alagoas, Av. Lourival de Melo Mota, s/n, CEP 57072-900 Maceió, AL, Brazil
| | - Heloise R de Barros
- Macromolecules and Interfaces Research Group, Department of Chemistry, UFPR, Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil; Laboratory of Electroactive Materials, Chemistry Institute, Universidade de São Paulo, Av Professor Lineu Prestes, 748, CEP 05513-970 São Paulo, SP, Brazil
| | - Beatriz S Borges
- Laboratory of Cell Biology, Instituto Carlos Chagas (ICC/Fiocruz), Rua Prof. Algacyr Munhoz Mader, 3775, CEP 81350-010 Curitiba, PR, Brazil
| | - Lia C A S de Medeiros
- Laboratory of Cell Biology, Instituto Carlos Chagas (ICC/Fiocruz), Rua Prof. Algacyr Munhoz Mader, 3775, CEP 81350-010 Curitiba, PR, Brazil
| | - Maurilio J Soares
- Laboratory of Cell Biology, Instituto Carlos Chagas (ICC/Fiocruz), Rua Prof. Algacyr Munhoz Mader, 3775, CEP 81350-010 Curitiba, PR, Brazil
| | - Mayara P Dos Santos
- Environmental Chemistry Group, Department of Chemistry, UFPR, Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Marco T Grassi
- Environmental Chemistry Group, Department of Chemistry, UFPR, Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Gustavo R Rossi
- Laboratory of Inflammatory and Neoplastic Cells/Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal do Paraná (UFPR), Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Daniel L Bellan
- Laboratory of Inflammatory and Neoplastic Cells/Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal do Paraná (UFPR), Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Stellee M P Biscaia
- Laboratory of Inflammatory and Neoplastic Cells/Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal do Paraná (UFPR), Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Aline M Cristal
- Laboratory of Inflammatory and Neoplastic Cells/Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal do Paraná (UFPR), Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - João L A Buzzo
- Laboratory of Inflammatory and Neoplastic Cells/Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal do Paraná (UFPR), Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Yasmin C Ribeiro
- Laboratory of Inflammatory and Neoplastic Cells/Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal do Paraná (UFPR), Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Alexandra Acco
- Department of Pharmacology, UFPR, Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Mateus B Cardoso
- Laboratório Nacional de Luz Síncrotron, Centro Nacional de Pesquisa em Energia e Materiais, Rua Giuseppe Máximo Scolfaro, 10000, CEP 13083-970, Campinas, SP, Brazil
| | - Fernanda F Simas
- Laboratory of Inflammatory and Neoplastic Cells/Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal do Paraná (UFPR), Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Edvaldo S Trindade
- Laboratory of Inflammatory and Neoplastic Cells/Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal do Paraná (UFPR), Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Izabel C Riegel-Vidotti
- Macromolecules and Interfaces Research Group, Department of Chemistry, UFPR, Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil
| | - Carolina C de Oliveira
- Laboratory of Inflammatory and Neoplastic Cells/Laboratory of Sulfated Polysaccharides Investigation, Cell Biology Department, Section of Biological Sciences, Universidade Federal do Paraná (UFPR), Av Cel Francisco H dos Santos, s/n, CEP 81530-980 Curitiba, PR, Brazil.
| |
Collapse
|